Prognostic factors predictive of response to bevacizumab combined with chemotherapy in recurrent ovarian cancer – A multi-institutional study

Saved in:
Bibliographic Details
Title: Prognostic factors predictive of response to bevacizumab combined with chemotherapy in recurrent ovarian cancer – A multi-institutional study
Authors: Alvarez-Secord, A.1, Huh, W.2, Tillmanns, T.3, Moore, K.4, Chapman, J.5, McClung, C.6, Kiet, T.5, Kattan, M.7, Java, J.8, Chan, J.5
Source: Gynecologic Oncology. Mar2012 Supplement, Vol. 125, pS98-S99. 0p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2011.12.235